Today we can announce that we are expanding within the production of cell therapy, i.a. via partnership with Alder Therapeutics and that we are expanding with a second manufacturing facility at Karolinska.
Read more via the links!
LinkedIN: https://www.linkedin.com/feed/update/urn:li:activity:6944894393241759744/
Extra good for NorthX if you like or share the LinkedIn post, thanks!
NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX Biologics has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.
For more news, follow us on LinkedIn
NorthX Biologics is entering a long term collaboration with Diamyd Medical and APL to support the preparation of retogatein (rhGAD65) for commercial manufacturing. Retogatein is being developed as a therapy aimed at preserving insulin producing cells in people with ...
Mendus’ lead cell therapy product for acute and chronic myeloid leukemias Matfors, Sweden, 12 01 2025. NorthX Biologics, a leading CDMO and Swedish national innovation hub for advanced biologics, and ...
Janet Hoogstraate on Sweden’s role in global biomanufacturing Sweden has built a strong foundation in life science, with world-class research environments, advanced infrastructure, and skilled professionals. In a recent interview ...